Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Thrombocytopenia 2Venous Thromboembolism 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, B-Cell 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Hematologic Diseases 1

Interventions

Cyclophosphamide 28Whole-Body Irradiation 20fludarabine phosphate 19Mycophenolic Acid 15Methotrexate 14fludarabine 13Cytarabine 13Busulfan 13Peripheral Blood Stem Cell Transplantation 11venetoclax 10Cord Blood Stem Cell Transplantation 10Tacrolimus 9Cyclosporine 9Vincristine 8Thiotepa 7Methylprednisolone 7Mercaptopurine 7Melphalan 7Filgrastim 7Dexamethasone 7Azacitidine 7Asparaginase 7Antilymphocyte Serum 7Hydrocortisone 6Daunorubicin 6merphos 5Specimen Handling 5Radiotherapy 5Granulocyte Colony-Stimulating Factor 5Cyclosporins 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia, Biphenotypic, Acute × Platelet Transfusion × Clear all
NCT03195010 2019-10-21

Management of Platelet Transfusion Therapy in Patients With Blood Cancer or Treatment-Induced Thrombocytopenia

Fred Hutchinson Cancer Center

Phase 2 Terminated
4 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Hematologic Diseases, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Venous Thromboembolism, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡